​Renerva®, LLC. is a rapidly-growing and innovative medical device company founded in 2017.

Our main focus is to develop and commercialize implantable technologies to improve the outcome of peripheral nerve repair procedures. Renerva’s initial therapeutic focus is on the 500,000 Americans suffering from acute nerve injuries every year, with other indications including the treatment of chronic compressive nerve injuries and other conditions affecting the peripheral nerves.

We are privately held and headquartered in Pittsburgh, Pennsylvania, where we operate in a state-of-the-art laboratory facility.

We are building a stellar team and nourishing a culture of high performance and team cohesiveness with the focused mission of helping patients affected by peripheral nerve injury by advancing nerve recovery and restoring the hope of achieving a good quality of life.

For the most recent news about Renerva®, LLC please visit www.renerva.com